Gritstone bio Inc reports results for the quarter ended in March - Earnings Summary

Gritstone bio

09/05/2024 23:39

* Gritstone bio Inc  GRTS.OQ  reported a quarterly adjusted
loss
of 34 cents​​ per share for the quarter ended in March, lower
than the same quarter last year, when the company reported EPS
of -30 cents.  The mean expectation of eight analysts for the
quarter was for a loss of 32 cents per share. Wall Street
expected results to range from -38 cents to -23 cents per share.
    * Revenue fell 28.7% to $1.74 million from a year ago;
analysts
expected $1.10 million. 
    * Gritstone bio Inc's reported EPS for the quarter was a
loss
of 34 cents​.
    * The company reported a quarterly loss of $40.39 million.
    * Gritstone bio Inc shares had fallen by 61.7% this
quarter and
lost 51.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 7% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Gritstone bio Inc
is $4.00 
This summary was machine generated from LSEG data May 9 at 10:38
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.32          -0.34          Missed
 Dec. 31 2023      -0.33          -0.26          Beat
 Sep. 30 2023      -0.33          -0.33          Met
 Jun. 30 2023      -0.35          -0.31          Beat